Sandbox/Alejandro: Difference between revisions
< Sandbox
Line 106: | Line 106: | ||
==Cellular Immune Deficient Patients== | ==Cellular Immune Deficient Patients== | ||
* Patients with cellular immunodeficiency require a pathogen-specific antimicrobial therapy. | |||
* The duration of antimicrobial therapy should be individualized in accordance with patient's clinical response. | |||
{| style="border: 2px solid #696969;" | |||
|+ <SMALL>''Recommended Duration of Antimicrobial Therapy Based on the Microorganism.''</SMALL> | |||
| style="background: #A5B2D6; border: 0px solid #696969; padding: 0 5px; width: 200px"| '''''Microorganism''''' || style="background: #A5B2D6; border: 0px solid #696969; padding: 0 5px; width: 200px" | '''Duration of Therapy''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5" align=left | ▸ '''''[[Nocardia spp]]''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ''''' 3-12 months''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5" align=left | ▸ '''''[[Atypical mycobacteria]]''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ''''' 3-6 weeks''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5" align=left | ▸ '''''[[Cryptococcus spp]]''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ''''' 8-12 weeks''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5" align=left | ▸ '''''[[Histoplasma spp]]''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ''''' xxx''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5" align=left | ▸ '''''[[Varicella-zoster virus]]''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ''''' 7-10 days''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5" align=left | ▸ '''''[[Herpes simplex virus]]''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ''''' 7 days''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5" align=left | ▸ '''''[[Cytomegalovirus]]''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ''''' 21 days''''' | |||
|- | |||
|} | |||
{| | {| | ||
| valign=top | | | valign=top | |
Revision as of 15:45, 5 June 2014
Neutropenic Patients
- Patients with neutropenia require an antimicrobial therapy with a broader coverage.
- The duration of antimicrobial therapy should be individualized in accordance with patient's clinical response.
Microorganism | Duration of Therapy |
▸ Gram-negative Bacteria | 7-14 days |
▸ Gram-positive Bacteria | 7-10 days |
▸ Fungi | Until clinical resolution |
▸ Click on the following categories to expand treatment regimens.
Neutropenia ▸ Gram-Negative Bacteria ▸ Gram-Positive Bacteria ▸ Fungi
|
|
Cellular Immune Deficient Patients
- Patients with cellular immunodeficiency require a pathogen-specific antimicrobial therapy.
- The duration of antimicrobial therapy should be individualized in accordance with patient's clinical response.
Microorganism | Duration of Therapy |
▸ Nocardia spp | 3-12 months |
▸ Atypical mycobacteria | 3-6 weeks |
▸ Cryptococcus spp | 8-12 weeks |
▸ Histoplasma spp | xxx |
▸ Varicella-zoster virus | 7-10 days |
▸ Herpes simplex virus | 7 days |
▸ Cytomegalovirus | 21 days |
Bacteria ▸ Nocardia spp ▸ Atypical mycobacteria Fungi ▸ Cryptococcus spp ▸ Histoplasma spp Viruses ▸ Varicella-zoster virus ▸ Herpes simplex virus ▸ Cytomegalovirus |
|
- ↑ Wheat, LJ.; Freifeld, AG.; Kleiman, MB.; Baddley, JW.; McKinsey, DS.; Loyd, JE.; Kauffman, CA. (2007). "Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America". Clin Infect Dis. 45 (7): 807–25. doi:10.1086/521259. PMID 17806045. Unknown parameter
|month=
ignored (help)